Implant Rehabilitation in Head and Neck Oncology

Head and neck malignancies frequently require extensive surgical resection and adjuvant radiotherapy, leaving patients with significant functional and aesthetic deficits. Implant rehabilitation has emerged as a cornerstone of multidisciplinary care, offering durable support for fixed and removable prostheses and restoring masticatory function, speech and facial contour. Advances in three-dimensional imaging, virtual surgical planning and patient-specific reconstructive techniques have enabled precise placement of endosseous implants in native and reconstructed jaws. Timing of implant insertion—whether at the time of tumour resection (primary placement) or after completion of oncologic treatment (secondary placement)—is tailored to individual risk factors, including radiation dose, bone quality and need for grafting. Outcomes have improved with refined loading protocols, bespoke grafting materials and adjuvant therapies to enhance osseointegration in irradiated bone. Ongoing work seeks to optimise patient selection, reduce complication rates such as osteoradionecrosis and mucosal overgrowth, and integrate novel biomaterials to further elevate long-term success and quality of life.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Implant Rehabilitation in Head and Neck Oncology publication trend

The graph below shows the total number of articles in implant rehabilitation in head and neck oncology across all publications each year (not limited to Nature Index journals).

Technical terms

Osseointegration: Stable anchorage of an endosseous implant achieved through direct bone-to-implant contact without intervening soft tissue.

Osteoradionecrosis: Progressive bone necrosis resulting from radiation-induced vascular compromise and cellular damage in irradiated jaw segments.

Grafted bone: Autologous or allogeneic bone tissue used to augment deficient jaw regions to facilitate implant placement.

Primary implant placement: Insertion of dental implants concurrently with tumour resection surgery to condense treatment phases and enable earlier rehabilitation.

Mucosal overgrowth: Excessive proliferation of peri-implant soft tissue, often in grafted sites, which can impede hygiene and prosthetic fit.

References

1. What is the optimal timing for implant placement in oral cancer patients? A scoping literature review. Oral Diseases (2020).
2. Survival of dental implants and occurrence of mucosal overgrowth in patients with head and neck cancer treated with/without radiotherapy and mucosal graft—two-year follow-up. Clinical Oral Investigations (2024).
3. Factors Influencing the Survival Rate of Teeth and Implants in Patients after Tumor Therapy to the Head and Neck Region—Part 2: Implant Survival. Journal of Clinical Medicine (2022).
4. Clinical performance of different types of dental prosthesis in patients with head and neck tumors—a retrospective cohort study. Clinical Oral Investigations (2022).